|
|
|
Insider
Information: |
Mcneill Jonathan |
Relationship: |
|
City: |
Waltham |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
136,634 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$4,355,892 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
136,634 |
|
|
Total
Value |
$4,355,892 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
|
|
Stock
price went down : |
|
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Dyne Therapeutics, Inc. |
DYN |
|
2024-05-16 |
136,634 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
37 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
DYN |
Dyne Therapeutics, Inc. |
Chief Business Officer |
|
2024-01-03 |
4 |
OE |
$0.73 |
$13,133 |
D/D |
17,991 |
161,609 |
0 |
- |
|
DYN |
Dyne Therapeutics, Inc. |
Chief Business Officer |
|
2024-03-11 |
4 |
AS |
$25.48 |
$499,842 |
D/D |
(19,601) |
139,408 |
0 |
% |
|
DYN |
Dyne Therapeutics, Inc. |
Chief Business Officer |
|
2024-01-26 |
4 |
OE |
$0.73 |
$14,600 |
D/D |
20,000 |
163,618 |
0 |
- |
|
DYN |
Dyne Therapeutics, Inc. |
Chief Business Officer |
|
2024-01-26 |
4 |
AS |
$24.52 |
$490,510 |
D/D |
(20,000) |
143,618 |
0 |
% |
|
DYN |
Dyne Therapeutics, Inc. |
Chief Business Officer |
|
2024-03-01 |
4 |
AS |
$28.25 |
$694,495 |
D/D |
(24,260) |
143,618 |
0 |
% |
|
DYN |
Dyne Therapeutics, Inc. |
Chief Business Officer |
|
2024-03-01 |
4 |
OE |
$0.73 |
$17,710 |
D/D |
24,260 |
167,878 |
0 |
- |
|
DYN |
Dyne Therapeutics, Inc. |
See Remarks |
|
2021-12-10 |
4 |
A |
$0.00 |
$0 |
D/D |
25,311 |
60,947 |
0 |
- |
|
DYN |
Dyne Therapeutics, Inc. |
See Remarks |
|
2023-01-09 |
4 |
AS |
$11.57 |
$348,836 |
D/D |
(30,150) |
67,600 |
0 |
% |
|
DYN |
Dyne Therapeutics, Inc. |
See Remarks |
|
2022-12-09 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
98,222 |
0 |
- |
|
DYN |
Dyne Therapeutics, Inc. |
Chief Business Officer |
|
2024-03-08 |
4 |
OE |
$5.54 |
$498,600 |
D/D |
90,000 |
231,184 |
0 |
- |
|
DYN |
Dyne Therapeutics, Inc. |
Chief Business Officer |
|
2024-03-08 |
4 |
AS |
$25.46 |
$2,361,531 |
D/D |
(90,000) |
141,184 |
0 |
% |
|
DYN |
Dyne Therapeutics, Inc. |
Chief Business Officer |
|
2023-11-15 |
4 |
A |
$0.00 |
$0 |
D/D |
96,158 |
156,763 |
0 |
- |
|
37 Records found
|
|
Page 2 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|